Several discussed NPs in this review are FDA or EMA approved carriers for anti-cancer drugs, including NP-bound albumin, iron oxide NPs, and lipid-based NPs (Wicki et al., 2015; Rodríguez et al., 2022), highlighting their safety and efficacy in delivering anti-cancer drugs, while other systems require further in vivo study. The gene discussed is ALB; the disease is cancer.